HMG-CoA Reductase Inhibitors for Traumatic Brain Injury

被引:0
作者
Kalman Katlowitz
Shankar Gopinath
Jovany Cruz Navarro
Claudia Robertson
机构
[1] Baylor College of Medicine,Department of Neurosurgery
来源
Neurotherapeutics | 2023年 / 20卷
关键词
Traumatic brain injury; Statins; Trauma; Inflammation; Concussion; Inflammation; Cholesterol;
D O I
暂无
中图分类号
学科分类号
摘要
Traumatic brain injuries (TBIs) are associated with high morbidity and mortality due to both the original insult as well as the destructive biological response that follows. Medical management aims to slow or even halt secondary neurological injury while simultaneously laying the groundwork for recovery. Statins are one class of medications that is showing increased promise in the management of TBI. Used extensively in cardiovascular disease, these drugs were originally developed as competitive inhibitors within the cholesterol production pipeline. They are now used in diverse disease states due to their pleiotropic effects on other biological processes such as inflammation and angiogenesis. Preclinical studies, retrospective reviews, and randomized clinical trials have shown a variety of benefits in the management of TBI, but to date, no large-scale randomized clinical trial has been performed. Despite this limitation, statins’ early promise and well-tolerated side effect profile make them a promising new tool in the management of TBIs. More bench and clinical studies are needed to delineate proper treatment regimens as well as understand their true potential.
引用
收藏
页码:1538 / 1545
页数:7
相关论文
共 115 条
  • [1] Maas AIR(2017)Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research Lancet Neurol 16 987-1048
  • [2] Feigin VL(2013)Incidence of traumatic brain injury in New Zealand: a population-based study Lancet Neurol 12 53-64
  • [3] Plassman BL(2000)Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias Neurology 55 1158-1166
  • [4] Mahler B(2015)Unprovoked seizures after traumatic brain injury: a population-based case-control study Epilepsia 56 1438-1444
  • [5] Hart T(2011)Major and minor depression after traumatic brain injury Arch Phys Med Rehabil 92 1211-1219
  • [6] Riggio S(2009)Neurobehavioral sequelae of traumatic brain injury Mount Sinai Journal of Medicine: J Transl Pers Med 76 163-172
  • [7] Wong M(2006)Surgical management of traumatic brain injury Neurosurgery 58 16-24
  • [8] Bullock MR(2008)Management of intracranial hypertension Neurol Clin 26 521-806
  • [9] Rangel-Castillo L(2016)Pharmacologic neuroprotection for functional outcomes after traumatic brain injury: a systematic review of the clinical literature CNS Drugs 30 791-38
  • [10] Gopinath S(2007)Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial Lancet Neurol 6 29-471